Impact of (18)F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative (131)I whole body scan and elevated serum thyroglobulin

OBJECTIVE(S): ( 18)F-FDG PET/CT is increasingly performed in patients with differen-tiated thyroid cancer. The aim of this study was to assess the clinical impact of (18)F-FDG PET/CT on the management of patients with differentiated thyroid carcinoma who had elevated serum thyroglobulin (Tg) and neg...

Descripción completa

Detalles Bibliográficos
Autores principales: Boktor, Raef R., Lee, Sze Ting, Berlangieri, Salvatore U., Scott, Andrew M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742852/
https://www.ncbi.nlm.nih.gov/pubmed/35083346
http://dx.doi.org/10.22038/AOJNMB.2021.58276.1406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742852/
https://www.ncbi.nlm.nih.gov/pubmed/35083346
http://dx.doi.org/10.22038/AOJNMB.2021.58276.1406

Ejemplares similares